Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis.

ABSTRACT:

Background

The objective of this study was to describe the real-world treatment and overall survival (OS) of German patients with a diagnosis of advanced non-small cell lung cancer (aNSCLC), and to explore factors associated with the real-world mortality risk.

Methods

This was a retrospective German claims data analysis of incident aNSCLC patients. Data were available from 01/01/2011 until 31/12/2016. Identification of eligible patients took place between 01/01/2012-31/12/2015, to allow for at least 1-year pre-index and follow-up periods. Inpatient and outpatient mutation test procedures after aNSCLC diagnosis were observed. Further, prescribed treatments and OS since first (incident) aNSCLC diagnosis and start of respective treatment lines were described both for all patien

SUBMITTER: Hardtstock F 

PROVIDER: S-EPMC7106673 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature